查找临床试验

已按「视神经脊髓炎」检索,对应国际通用词 neuromyelitis optica

试验不在中国怎么办?

共找到 12 项正在招募的试验(在欧美日韩等发达国家设有中心)

数据更新于 11:18,每 5 分钟自动同步
正在招募不适用NCT03900221

French Registry for Monitoring Pregnancies for Multiple Sclerosis

France、Martinique

年龄 不限不限

Hospices Civils de Lyon

正在招募II 期NCT06453694

Efgartigimod for the Treatment of Acute Optic Neuritis

United States

年龄 18 Years不限

Anastasia Vishnevetsky, MD, MPH

正在招募不适用NCT07202494

Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging

France

年龄 18 Years90 Years

Assistance Publique Hopitaux De Marseille

正在招募III 期NCT05349006

Azathioprine in MOGAD

France

年龄 18 Years不限

Hospices Civils de Lyon

正在招募不适用NCT06780709

Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD

United States

年龄 18 Years不限

Icahn School of Medicine at Mount Sinai

正在招募不适用NCT05204459

MS-ResearchBiomarkerS

United States

年龄 18 Years不限

Cedars-Sinai Medical Center

正在招募不适用NCT06280755

Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.

Czechia、Germany

年龄 18 Years不限

icometrix

正在招募不适用NCT05909761

Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy

United States

年龄 15 Years不限

Amgen

正在招募不适用NCT05566769

Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD

United States、France、Germany

年龄 18 Years不限

Ad scientiam

正在招募不适用NCT06312644

Study of Ultomiris® (Ravulizumab) Safety in Pregnancy

United States、Australia、France、Germany、Italy 等 7 国

年龄 不限不限

Alexion Pharmaceuticals, Inc.

正在招募不适用NCT03011541

Stem Cell Ophthalmology Treatment Study II

United States、Austria、United Arab Emirates

年龄 18 Years不限

MD Stem Cells

正在招募不适用中国有中心NCT05966467

Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies

United States、Argentina、Canada、China、Germany 等 8 国

年龄 18 Years不限

Alexion Pharmaceuticals, Inc.